Conrad Wai, CEO, Counterpart Health at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), sold 15,203 shares at $3.26 ($50K) on 2025-07-08, disclosed to the SEC on 2025-07-10.
Scheduled sale ($50k) by CEO, Counterpart Health under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CLOV | SELL | 2026-05-28 | $879K | — | Filing → |
| CLOV | SELL | 2025-07-24 | $996K | — | Filing → |